Post Type Archives: News

Lonza today announced that its Board of Directors has approved the appointment of Jason Berndt as Head of Group Operations, Executive Vice President and member of the EC. Jason succeeds Maria Soler Nunez, who will take up the newly-created role of Chief Quality Officer and Executive Vice President, remaining a member of the EC. Both […]

The board of Inizio, a leading commercialisation partner to health and life sciences companies globally, has announced the appointment of Ryan Quigley as Chief Executive Officer, effective 9 September 2025. Ryan succeeds Paul Taaffe, who will continue to work with Ryan to support the transition until the end of the year. Ryan has served as […]

Novo Nordisk announced a company-wide transformation to simplify its organisation, improve the speed of decision-making, and reallocate resources towards the company’s growth opportunities in diabetes and obesity. As part of the transformation, Novo Nordisk intends to reduce the global workforce by approximately 9,000 of the 78,400 positions in the company, with around 5,000 reductions expected […]

Symeres, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announces the acquisition of DGr Pharma, a drug development-focused consultancy, to expand its integrated early-stage drug development services and accelerate IND-enabling capabilities for biopharma clients. The acquisition is supported by Keensight Capital (“Keensight”), one of the leading private equity managers dedicated to pan-European Growth […]

Eli Lilly and Company announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that provides biotech companies access to drug discovery models trained on years of Lilly’s research data. Lilly estimates that this first release of AI models includes proprietary data obtained at a cost of over $1 billion, representing […]

Addressing a critical need in drug development Almac Group has completed a multi-million-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK. The significant investment by Almac Pharma Services, will address ongoing industry challenges around solubility and growing global demand for advanced formulation solutions.  The investment includes the installation of Buchi S300 […]

SIRIO Pharma (SIRIO) – the global nutraceutical contract development and manufacturing organization (CDMO) – announces that its Ma’anshan facility in China has been granted a Certificate of GMP Compliance by the Therapeutic Goods Administration (TGA) of Australia. The approval will support SIRIO’s expansion into the rapidly growing Australian market, providing both local and international brands […]

Informa Markets will once again welcome the global pharmaceutical industry to CPHI Frankfurt 2025, running from October 28 to 30 at Messe Frankfurt. The three-day event is expected to draw more than 63,000 attendees, with six content theatres, more than 2,000 exhibitors, and a packed programme dedicated to networking and innovation. Celebrating its 36th year, […]

Synbiotic formulation demonstrates dual therapeutic effect on gastrointestinal symptoms and anxiousness Key Highlights BK002 achieved an 83% responder rate. A significant alleviation of gastrointestinal symptoms in IBS patients. A significant reduction in anxiousness. BiOkuris announced positive topline results from its pivotal clinical study, Vitabiotic, evaluating BK002, the company’s synbiotic formulation for the treatment of Irritable […]

Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced an agreement with Rodon Global (“Rodon”), the established freight company focused on clinical trials and drug discovery headquartered in South Africa. The collaboration comes at a pivotal time as Rodon actively expands operations across the United States, […]